These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 5080759)

  • 41. Lack of N-hydroxy-2-acetylaminofluorene sulfotransferase activity in the mammary gland and Zymbal's gland of the rat.
    Irving CC; Janss DH; Russell LT
    Cancer Res; 1971 Apr; 31(4):387-91. PubMed ID: 5553685
    [No Abstract]   [Full Text] [Related]  

  • 42. Reactions in vitro of some tissue nucleophiles with the glucuronide of the carcinogen N-hydroxy-2-acetylaminofluorene.
    Miller EC; Lotlikar PD; Miller JA; Butler BW; Irving CC; Hill JT
    Mol Pharmacol; 1968 Mar; 4(2):147-54. PubMed ID: 5650958
    [No Abstract]   [Full Text] [Related]  

  • 43. Differential induction of N(2),3-ethenoguanine in rat brain and liver after exposure to vinyl chloride.
    Morinello EJ; Koc H; Ranasinghe A; Swenberg JA
    Cancer Res; 2002 Sep; 62(18):5183-8. PubMed ID: 12234982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat.
    Gutmann HR; Malejka-Giganti D; Barry EJ; Rydell RE
    Cancer Res; 1972 Jul; 32(7):1554-61. PubMed ID: 4337834
    [No Abstract]   [Full Text] [Related]  

  • 45. Metabolism and biliary excretion of N-2-fluorenylacetamide and N-hydroxy-2-fluorenylacetamide.
    Levine WG
    Life Sci II; 1971 Jul; 10(13):727-35. PubMed ID: 5561052
    [No Abstract]   [Full Text] [Related]  

  • 46. Dehydroxylation and deacetylation of N-hydroxy-N-2-fluorenylacetamide by rat liver and brain homogenates.
    Grantham PH; Weisburger EK; Weisburger JH
    Biochim Biophys Acta; 1965 Oct; 107(3):414-24. PubMed ID: 5867299
    [No Abstract]   [Full Text] [Related]  

  • 47. Phenobarbital-mediated increase in ring- and N-hydroxylation of the carcinogen N-2-fluorenylacetamide, and decrease in amounts bound to liver deoxyribonucleic acid.
    Matsushima T; Grantham PH; Weisburger EK; Weisburger JH
    Biochem Pharmacol; 1972 Aug; 21(15):2043-51. PubMed ID: 4645881
    [No Abstract]   [Full Text] [Related]  

  • 48. Inhibitors of chemical carcinogens as probes for molecular targets: DNA as decisive receptor for metabolite from N-hydroxy-N-2-fluorenylacetamide.
    Matsushima T; Weisburger JH
    Chem Biol Interact; 1969 Dec; 1(2):211-21. PubMed ID: 5407060
    [No Abstract]   [Full Text] [Related]  

  • 49. Enzyme-catalyzed reactions of the carcinogen N-hydroxy-2-fluorenylacetamide with nucleic acid.
    King CM; Phillips B
    Science; 1968 Mar; 159(3821):1351-3. PubMed ID: 5644261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Covalent binding of 2-acetylaminofluorene, 2-aminofluorene, and N-hydroxy-2-acetylaminofluorene to rat liver nuclear DNA and protein in vivo and in vitro.
    Stout DL; Hemminki K; Becker FF
    Cancer Res; 1980 Oct; 40(10):3579-84. PubMed ID: 7438044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolism of continuously fed 14C-labeled N-hydroxy-N-2-fluorenylacetamide at various intervals: effect of pituitary hormones.
    Shirasu Y; Grantham PH; Weisburger EK; Weisburger JH
    Cancer Res; 1967 May; 27(5):865-72. PubMed ID: 4290554
    [No Abstract]   [Full Text] [Related]  

  • 52. The reaction of specific antibody with 2-acetylaminofluorene fixed in liver cells.
    Tanigaki N; Kitagawa M; Yagi Y; Pressman D
    Cancer Res; 1967 Apr; 27(4):747-51. PubMed ID: 4290626
    [No Abstract]   [Full Text] [Related]  

  • 53. Formation of DNA adducts in liver of rats treated with 2-aminofluorene. Differences between total and matrix attached DNA fractions.
    Widłak P; Rzeszowska-Wolny J
    Acta Biochim Pol; 1990; 37(1):65-7. PubMed ID: 2087917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. On the mechanism of action of carcinogenic aromatic amines. II. Binding of N-hydroxy-N-acetyl-4-aminobiphenyl to rat-liver nucleic acids in vitro.
    Kriek E
    Chem Biol Interact; 1971 Feb; 3(1):19-28. PubMed ID: 5156323
    [No Abstract]   [Full Text] [Related]  

  • 55. Mechanisms of cytochrome P450 1A2-mediated formation of N-hydroxy arylamines and heterocyclic amines and their reaction with guanyl residues.
    Guengerich FP; Humphreys WG; Yun CH; Hammons GJ; Kadlubar FF; Seto Y; Okazaki O; Martin MV
    Princess Takamatsu Symp; 1995; 23():78-84. PubMed ID: 8844798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pattern of methylated purines formed in DNA of intact and regenerating liver of rats treated with the carcinogen dimethylnitrosamine.
    Craddock VM
    Biochim Biophys Acta; 1973 Jun; 312(2):202-10. PubMed ID: 4353091
    [No Abstract]   [Full Text] [Related]  

  • 57. Covalent binding of benzidine and N-acetylbenzidine to DNA at the C-8 atom of deoxyguanosine in vivo and in vitro.
    Martin CN; Beland FA; Roth RW; Kadlubar FF
    Cancer Res; 1982 Jul; 42(7):2678-86. PubMed ID: 7083160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of the carcinogen N-acetoxy-2-fluorenylacetamide on the template properties of deoxyribonucleic acid.
    Zieve FJ
    Mol Pharmacol; 1973 Sep; 9(5):658-69. PubMed ID: 4363017
    [No Abstract]   [Full Text] [Related]  

  • 59. Interaction of urethan with macromolecules in male and female newborn, adult, and tumor-bearing mice.
    Chavon BG; Bhide SV
    J Natl Cancer Inst; 1972 Oct; 49(4):1019-25. PubMed ID: 5084120
    [No Abstract]   [Full Text] [Related]  

  • 60. Formation of electrophilic N-acetoxyarylamines in cytosoles from rat mammary gland and other tissues by transacetylation from the carcinogen N-hydroxy-4-acetylaminobiphenyl.
    Bartsch H; Dworkin C; Miller EC; Miller JA
    Biochim Biophys Acta; 1973 Mar; 304(1):42-55. PubMed ID: 4699998
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.